DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,320 | +2.7% | 2,308,028 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $27,579 | +23.9% | 2,309,731 | +38.7% | 0.00% | +33.3% |
| Q1 2023 | $22,259 | -52.6% | 1,664,751 | -23.7% | 0.00% | -62.5% |
| Q4 2022 | $46,969 | -99.9% | 2,182,578 | +4.2% | 0.01% | +14.3% |
| Q3 2022 | $41,962,000 | +14.8% | 2,094,913 | +2.6% | 0.01% | +40.0% |
| Q2 2022 | $36,540,000 | +132.3% | 2,041,344 | +28.7% | 0.01% | +150.0% |
| Q1 2022 | $15,731,000 | -40.9% | 1,585,741 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $26,639,000 | -23.6% | 1,580,978 | +5.0% | 0.00% | -33.3% |
| Q3 2021 | $34,865,000 | +4.3% | 1,506,326 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $33,434,000 | – | 1,505,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |